Target intelligence / Profile preview

Alpha-actinin-4 (ACTN4)

Target
ACTN4
Molecular classification
Cytoskeletal protein, Actin-binding protein, Spectrin superfamily
01

Overview

Alpha-actinin–4 is a non-muscle isoform of the alpha-actinin family, encoded by the ACTN4 gene. It is a member of the spectrin superfamily and functions as an antiparallel homodimer that crosslinks filamentous actin (F-actin) in the cytoplasm. The protein contains an N-terminal actin-binding domain with calponin homology domains, a central rod domain for dimerization, and a C-terminal calmodulin-like domain with EF-hand motifs. Alpha-actinin–4 plays essential roles in organizing the actin cytoskeleton, maintaining cell shape, facilitating focal adhesion dynamics through interactions with integrins at the plasma membrane, and regulating cell motility. It is ubiquitously expressed in non-muscle cells but can also be found in neoplastic tissues. Mutations in alpha-actinin–4 are associated with autosomal dominant forms of kidney disease such as focal segmental glomerulosclerosis; these mutations often increase its affinity for F-actin or disrupt normal regulation by calcium ions[1][2][3][5]. In cancer biology, altered expression or function has been linked to increased metastatic potential due to changes in cellular adhesion and migration properties. No approved drugs are known to directly target alpha-actinin–4; it is not currently considered a direct therapeutic target such as receptors or enzymes but rather serves critical structural roles within cells[6].

Other names
Alpha actinin 4ACTN4Non-muscle alpha-actinin 4
02

Biological functions

Crosslinking and bundling of actin filamentsMaintenance of cell shape and cytoskeletal architectureRegulation of cell motility and migrationFocal adhesion formation and maturationLinking actin cytoskeleton to plasma membrane via integrins
03

Disease associations

Kidney disease (notably focal segmental glomerulosclerosis)Cancer progression/metastasis

Beyond the preview

Go deeper on Alpha-actinin-4 (ACTN4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-actinin-4 (ACTN4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call